<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01690806</url>
  </required_header>
  <id_info>
    <org_study_id>OTO: OTO12-0447R</org_study_id>
    <nct_id>NCT01690806</nct_id>
  </id_info>
  <brief_title>Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy</brief_title>
  <official_title>Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy (and Not Only) After Thyroid Surgery. A Randomized Double-blind Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Aquila</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Aquila</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recurrent laryngeal nerve dysfunction and hypoparathyroidism are well-recognized important
      complications of thyroid surgery. The duration of convalescence, after non complicated
      thyroid operation, may depend on several factors of which pain and fatigue are the most
      important. Nausea and vomiting occur mainly on the day of operation. Glucocorticoids are well
      known for their analgesic, anti-inflammatory, immune modulating and antiemetic effects. The
      investigators therefore undertook the present study to investigate whether preoperative
      dexamethasone could improve surgical outcome in patients undergoing thyroid surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">328</enrollment>
  <condition>Benign Neoplasm of Thyroid Gland</condition>
  <condition>Malignant Neoplasm of Thyroid</condition>
  <arm_group>
    <arm_group_label>dexamethasone</arm_group_label>
    <description>Patients who receive dexamethasone (8 mg; Decadron; Merck Sharp &amp; Dohme) intravenously 90 min before skin incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <description>Patients who receive saline placebo intravenously 90 min before skin incision</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing thyroid surgery for benign and malignant thyroidal disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing thyroid surgery

        Exclusion Criteria:

          -  ASA physical class III or IV

          -  age &gt; 75 years

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emanuela M CECILIA, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Aquila</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ospedale San Salvatore-Reparto di Chirurgia Generale Universitaria</name>
      <address>
        <city>L'Aquila</city>
        <state>AQ</state>
        <zip>67100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2012</study_first_submitted>
  <study_first_submitted_qc>September 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2012</study_first_posted>
  <last_update_submitted>September 25, 2012</last_update_submitted>
  <last_update_submitted_qc>September 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Aquila</investigator_affiliation>
    <investigator_full_name>CECILIA Emanuela Marina</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Vocal Cord Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

